Series C - Innate Pharma - Sep 1, 2004 Funding Round Profile - Cointime

Bitcoin $93,413.29 -2.34%
Ethereum $3,364.43 +1.12%
BNB $684.28 +4.21%
Optimism $1.83 +2.36%
Arbitrum $0.77 +2.52%
Solana $185.51 +1.44%
Polygon $0.48 +0.23%
Cosmos $6.61 +0.76%
Avalanche $37.28 -0.49%

Bitcoin $93,413.29 -2.34%
Ethereum $3,364.43 +1.12%
BNB $684.28 +4.21%
Optimism $1.83 +2.36%
Arbitrum $0.77 +2.52%
Solana $185.51 +1.44%
Polygon $0.48 +0.23%
Cosmos $6.61 +0.76%
Avalanche $37.28 -0.49%

Innate Pharma

company

Funding Round

Series C

Money Raised

€ 15M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Novo Nordisk	-	-	-	Detail
Akka Venture	-	-	-	Detail
NIF SMBC Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jan 1, 2002	Series B	€ 20M	Akka Venture	Detail